Speck introduces new iPhone 5s case with slim-fitting design
MOUNTAIN VIEW, Calif. — Speck, a designer of slim-fitting protective cases and covers for smartphones, tablets and laptops, on Tuesday announced a new iPhone case for the iPhone 5 and 5s.
Speck’s Candyshell + Faceplate is sleek and offers all-over protection for the consumer’s smartphone, the company stated. The Candyshell is a patented dual-layer protection system in a single piece. The hard outer shell protects against impact, while the soft inner layer absorbs shock. It has a protective faceplate that applies to the device’s screen and provides superior touch response, Speck stated. The faceplate also has an opening on the home button compatible with Apple’s new Touch ID fingerprint identity sensor.
“With CandyShell + Faceplate we wanted to offer in slim protection what others have been offering in bulk protection,” says Bryan Hynecek, vice president of design at Speck. “We engineered this iPhone 5s/5 case to deliver durability and 360-degree protection, plus Speck’s signature color and style, that preserves the beauty of the device.”
CandyShell + Faceplate will be available in the most popular CandyShell colors, including black/slate gray, white/charcoal gray, pomodoro red/black, carnation pink/revolution purple, white/raspberry pink and raspberry pink/black, each of which feature the matching CandyShield faceplate for an additional and protective extension. All Speck cases are lab-tested for proven protection against environmental factors and everyday bumps, drops and spills.
The iPhone 5s is available Friday, Sept. 20.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.
FDA approves Lupin’s generic version of Ambien CR
BALTIMORE — The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.
The FDA approved zolpidem tartrate extended-release tablets in the 6.25-mg and 12.5-mg strengths, a generic version of Sanofi’s Ambien CR.
The branded version of the drug had sales of $366 million during the 12-month period ended in March, according to IMS Health.
Market saturation to cause electronic health record market to decline
TORONTO — Market saturation will drive down the market for electronic medical records in the United States despite a spike last year resulting from government incentive funding, according to a new study.
The Millennium Research Group predicts that due to Medicare penalties for hospitals and physicians that fail to demonstrate meaningful use of electronic medical records by 2015, most adoption will occur by then. But market saturation means that purchases of new systems will likely decline.
"Most large facilities have already adopted these systems because they had the necessary capital and information technology resources to accommodate EMR implementation early on," MRG senior analyst Mickel Phung said. "as a result, most system purchases through 2022 will consist of replacement sales and purchases made by smaller facilities that previously could not afford the systems."
MRG suggested that companies making EMR systems target smaller facilities and physician practices or such niche segments as specialists, and web-based systems also presented further opportunities because they’re a major driver for ambulatory systems.